X-153536429-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001001344.3(ATP2B3):c.182G>A(p.Arg61Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000834 in 1,199,286 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001344.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP2B3 | NM_001001344.3 | c.182G>A | p.Arg61Gln | missense_variant | 3/22 | ENST00000263519.5 | NP_001001344.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP2B3 | ENST00000263519.5 | c.182G>A | p.Arg61Gln | missense_variant | 3/22 | 1 | NM_001001344.3 | ENSP00000263519 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000354 AC: 4AN: 113002Hom.: 0 Cov.: 25 AF XY: 0.0000284 AC XY: 1AN XY: 35162
GnomAD4 exome AF: 0.00000552 AC: 6AN: 1086284Hom.: 0 Cov.: 31 AF XY: 0.00000563 AC XY: 2AN XY: 355302
GnomAD4 genome AF: 0.0000354 AC: 4AN: 113002Hom.: 0 Cov.: 25 AF XY: 0.0000284 AC XY: 1AN XY: 35162
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 19, 2024 | The c.182G>A (p.R61Q) alteration is located in exon 1 (coding exon 1) of the ATP2B3 gene. This alteration results from a G to A substitution at nucleotide position 182, causing the arginine (R) at amino acid position 61 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at